US 11918557
Treatment of circadian rhythm disorders
granted A61KA61K31/00A61K31/15
Quick answer
US patent 11918557 (Treatment of circadian rhythm disorders) held by VANDA PHARMACEUTICALS INC. expires Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VANDA PHARMACEUTICALS INC.
- Grant date
- Tue Mar 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/00, A61K31/15, A61K31/277, A61K31/343